We are live on ! Find out more
HIM

Hillhouse Investment Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 7.29%
This Fund
S&P 500
This Quarter Est. Return
-29.33%
1 Year Est. Return
-7.29%
3 Year Est. Return
+122.05%
5 Year Est. Return
+101.44%
10 Year Est. Return
–
AUM
$1.34B
AUM Growth
-$2.41B
Cap. Flow
-$1.74B
Cap. Flow %
-130.67%
Top 10 Hldgs %
92.55%
Holding
52
New
2
Increased
8
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$675M
2
UXIN
Uxin Ltd
UXIN
+$117M
3
META icon
Meta Platforms (Facebook)
META
+$25.2M
4
MRNA icon
Moderna
MRNA
+$16.1M
5
AAPL icon
Apple
AAPL
+$8.66M

Top Sells

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$589M
2
JD icon
JD.com
JD
+$462M
3
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$220M
4
WUBA
58.com Inc
WUBA
+$194M
5
KYNB
Kyntra Bio
KYNB
+$163M

Sector Composition

Rank Sector Weight
1 Communication Services 42.21%
2 Financials 23.87%
3 Consumer Discretionary 16.35%
4 Healthcare 15.52%
5 Technology 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQ icon
1
iQIYI
IQ
$1.23B
$510M 38.21%
34,313,024
+32,333,917
+1,634% +$675M
ESGR
2
DELISTED
Enstar Group
ESGR
$293M 21.93%
1,747,840
– –
ONC
3
BeOne Medicines Ltd
ONC
$32.8B
$145M 10.86%
1,034,306
-4,437,953
-81% -$589M
UXIN
4
Uxin Ltd
UXIN
$306M
$108M 8.1%
222,502
+202,188
+995% +$117M
BABA icon
5
Alibaba
BABA
$293B
$54.2M 4.06%
395,340
-25,662
-6% -$3.79M
PDD icon
6
Pinduoduo
PDD
$126B
$32.3M 2.42%
1,440,605
-681,291
-32% -$14.4M
META icon
7
Meta Platforms (Facebook)
META
$1.42T
$30.9M 2.31%
235,374
+173,704
+282% +$25.2M
APLS
8
DELISTED
Apellis Pharmaceuticals
APLS
$27.7M 2.07%
2,098,581
-2,229,708
-52% -$34.2M
MSCI icon
9
MSCI
MSCI
$41.6B
$17.2M 1.29%
116,701
+44,317
+61% +$6.75M
AAPL icon
10
Apple
AAPL
$4.54T
$17.2M 1.29%
435,692
+178,544
+69% +$8.66M
MRNA icon
11
Moderna
MRNA
$21.8B
$14.9M 1.12%
+978,434
New +$16.1M
AMZN icon
12
Amazon
AMZN
$2.92T
$11.9M 0.89%
158,720
+88,520
+126% +$7.36M
JD icon
13
JD.com
JD
$44.6B
$11.7M 0.88%
558,400
-20,653,725
-97% -$462M
GSAH.U
14
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
$10.3M 0.77%
1,000,000
– –
RDGT
15
Ridgetech Inc
RDGT
$2.74M
$9.68M 0.72%
134
– –
BILI icon
16
Bilibili
BILI
$7.99B
$9.11M 0.68%
624,500
+610,439
+4,341% +$8.55M
BRK.A icon
17
Berkshire Hathaway Class A
BRK.A
$1.1T
$7.65M 0.57%
25
-26
-51% -$8.14M
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.36T
$6.92M 0.52%
133,580
+26,440
+25% +$1.42M
NFLX icon
19
Netflix
NFLX
$299B
$6.5M 0.49%
242,920
-80,900
-25% -$2.42M
RCUS icon
20
Arcus Biosciences
RCUS
$3.55B
$3.69M 0.28%
342,128
-425,000
-55% -$4.96M
ARVN icon
21
Arvinas
ARVN
$518M
$2.96M 0.22%
230,308
-625,000
-73% -$9.91M
NTGN
22
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$2.01M 0.15%
399,308
-312,500
-44% -$2.19M
CNST
23
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.27M 0.1%
317,921
– –
APO icon
24
Apollo Global Management
APO
$72.4B
$925K 0.07%
+37,678
New +$1.08M
BEDU
25
DELISTED
Bright Scholar Education Holdings
BEDU
– –
-996,449
Closed -$49.4M
1
2 3

Similar funds

GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
KPAG
KLS Professional Advisors Group New York $2.15B AUM 6.46% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
WJA
Williams Jones & Associates New York $4.82B AUM 19.95% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
LC
Lourd Capital Beverly Hills, California $1.08B AUM 8.79% 1-Year Est. Return
LIC
Lodestar Investment Counsel Chicago, Illinois $974M AUM 13.79% 1-Year Est. Return

Hillhouse Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Hillhouse Investment Management held 52 positions worth $1.34B, down 64% from $3.74B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Hillhouse Investment Management withdrew a net $1.74B in Q4 2018, closing 28 positions and reducing 10 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $220M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 42% of assets, up from 6.9% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Hillhouse Investment Management opened a new position in Moderna worth $14.9M.

  • Hillhouse Investment Management's largest Q4 2018 buy was Moderna: 978,434 shares worth $14.9M.
  • Hillhouse Investment Management added most to iQIYI in Q4 2018, an estimated $675M increase.
  • Hillhouse Investment Management's biggest Q4 2018 reduction was BeOne Medicines Ltd, cutting an estimated $589M.
  • Hillhouse Investment Management fully exited China Biologic Products Holdings, Inc. in Q4 2018, selling an estimated $220M.
  • Hillhouse Investment Management's ten largest holdings make up 93% of its $1.34B portfolio in Q4 2018.
  • Hillhouse Investment Management opened 2 new positions and closed 28 in Q4 2018.
  • Hillhouse Investment Management's portfolio value fell 64% quarter-over-quarter to $1.34B.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.